TY  - JOUR
AU  - Rodriguez-Gallego, Esther
AU  - Gomez, Josep
AU  - Pacheco, Yolanda M
AU  - Peraire, Joaquim
AU  - Vilades, Consuelo
AU  - Beltran-Debon, Raul
AU  - Mallol, Roger
AU  - Lopez-Dupla, Miguel
AU  - Veloso, Sergi
AU  - Alba, Veronica
AU  - Blanco, Julia
AU  - Cañellas, Nicolau
AU  - Rull, Anna
AU  - Leal, Manuel
AU  - Correig, Xavier
AU  - Domingo, Pere
AU  - Vidal, Francesc
PY  - 2018
DO  - 10.1097/QAD.0000000000001730
UR  - http://hdl.handle.net/10668/11953
T2  - AIDS (London, England)
AB  - Poor immunological recovery in treated HIV-infected patients is associated with greater morbidity and mortality. To date, predictive biomarkers of this incomplete immune reconstitution have not been established. We aimed to identify a baseline...
LA  - en
PB  - Lippincott Williams & Wilkins
KW  - antiretroviral therapy
KW  - biomarkers
KW  - HIV-1
KW  - metabolomics
KW  - poor immune recovery
KW  - Adult
KW  - Anti-Retroviral Agents
KW  - CD4 Lymphocyte Count
KW  - Female
KW  - Follow-Up Studies
KW  - HIV Infections
KW  - Humans
KW  - Magnetic Resonance Spectroscopy
KW  - Male
KW  - Metabolome
KW  - Middle Aged
KW  - Prospective Studies
KW  - Treatment Outcome
TI  - A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients.
TY  - research article
VL  - 32
ER  -